EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

The BORN Korea (475560) fair value: what the stock is really worth

As of Oct 8, 2026: fair value of The BORN Korea KRW 10,108, price KRW 14,100, upside -28.3%, quality 41 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Cyclical · KR

TB Thin data Oct 2, 2026

The BORN Korea

475560 · KO

Weak valuationQuality is weak on top of the rich price.

Low debt
Quality 41/100
Expensive Growth (revenue 5y +19.1 %/yr in KRW)
3.5% dividend yield · Watch coverage
Insider activity 45/100
Fair value 10,108 KRW · Overvalued (−28.3%)
Loss-making · -1.9% net margin (TTM)
Negative free cash flow
Trails peers (3/9)
Narrow moat 18/100
Thin data

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

50,009 KRW 12,700 KRW Fair Value 10,108 KRW Nov 2024 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.

How to read this chart

23‑month range 12,700 KRW – 50,009 KRW · fair‑value band 6,671 KRW – 12,635 KRW · the 14,100 KRW price screens above the 10,108 KRW fair value. Dashed = 300-day average. As of Oct 2, 2026.

Follow The BORN Korea in your weekly email

Every Wednesday you see whether The BORN Korea is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

The Born Korea engages in the restaurant business. It operates direct and franchise restaurants in South Korea, the United States, China, Japan, Singapore, Indonesia, Malaysia, the Philippines, and Vietnam. The company was founded in 1993 and is headquartered in Seoul, South Korea.

Stock analysis

The BORN Korea (475560) currently trades at 14,100 KRW, while our model-based Fair Value estimate is 10,108 KRW, 28.3% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: 6,671 KRW (bear) to 12,635 KRW (bull), the price of 14,100 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Consumer Cyclical sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

The BORN Korea reported revenue of 361B KRW in FY2025 versus 194B KRW in FY2021, a compound +16.8%/yr. Reported net income was −17.4B KRW in FY2025.

Key figures

Market cap 208B KRW (≈ $155M) · P/S ratio 0.63 · Dividend yield 3.5% · Net margin −4.8% · Return on equity −2.7% · Return on assets (EBIT) 8.6% · Operating margin −6.7% · Revenue (TTM) 339B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).

What moves the price

The share trades about 46% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at −18% fair-value upside, at −28%, 475560 screens richer than that median.

Fair Value models

Bear 6,671 KRW Fair Value 10,108 KRW Bull 12,635 KRW
Price 14,100 KRW · Upside -28.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 8,295 KRW 11,115 KRW 16,590 KRW 54
All 1 models by family
Asset-Based
NCAV (Graham) 8,295 KRW 11,115 KRW 16,590 KRW 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 41/100

Of which business quality 41 · Market factors (momentum, volatility) 22

Profitability 29
Margins and returns on capital today
Quality Growth 0
Are margins and returns improving?
Cashflow 26
Earnings quality: real cash, not paper profit
Fin. Strength 79
Balance sheet, leverage, solvency risk
Investment 29
Disciplined investing over empire-building
Low Volatility 46
Calm price path (market factor)
Momentum 15
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 74
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−22.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.1%
Start year 2020 (pandemic)
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
5.5% (2020) → −6.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

475560 screens overvalued: fair value 28% below the price. Compare with McDonald's Corporation →

Compare The BORN Korea with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Restaurants · 210 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 41 · Bottom 25%
Fair Value upside −28.3% · Below median
Profitability
Return on assets −3.5% · Bottom 25%
Net margin (TTM) −1.9% · Below median
Operating margin (TTM) −6.7% · Bottom 25%
Growth and dividend
Revenue growth 12.2% · Top 25%
Dividend yield (TTM) 3.5% · Above median
Balance sheet
Debt / equity 0.00× · Lowest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 38
FUTURE (revenue growth)61 · sector 19
PAST (return on equity)0 · sector 25
HEALTH (low debt)100 · sector 94
DIVIDEND (yield)71 · sector 63

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Restaurants stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Yum China Holdings YUMC $39.98 $50.76 +27% vs 475560
Chipotle Mexican Grill, Inc CMG $30.77 $33.85 +10% vs 475560
Restaurant Brands International Inc QSR $69.91 $73.34 +5% vs 475560
Darden Restaurants, Inc DRI $199.75 $175.20 −12% vs 475560
Texas Roadhouse, Inc TXRH $156.14 $128.55 −18% vs 475560
Domino's Pizza, Inc DPZ $297.62 $233.22 −22% vs 475560
McDonald's Corporation MCD $231.89 $162.81 −30% vs 475560
Yum! Brands, Inc YUM $136.12 $76.78 −44% vs 475560
Starbucks Corporation SBUX $94.43 $35.83 −62% vs 475560
Dutch Bros Inc BROS $37.89 $10.27 −73% vs 475560

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "The BORN Korea Fair Value". https://www.fairvalue-calculator.com/stock/475560

Frequently asked questions

Is The BORN Korea (475560) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of 10,108 KRW versus a price of 14,100 KRW, about −28% upside (overvalued).
What is the fair value of 475560?
Our model-based fair value for The BORN Korea is 10,108 KRW (as of Oct 2, 2026), built from audited fundamentals. The current price: 14,100 KRW.
What is the quality score of 475560?
The BORN Korea has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for The BORN Korea (475560)?
Our model-based price target is the fair value of 10,108 KRW (as of Oct 2, 2026) from 1 valuation models. Cautious scenario 6,671 KRW, optimistic scenario 12,635 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the The BORN Korea stock forecast for 2026?
Our models put fair value at 10,108 KRW, about −28% upside versus a price of 14,100 KRW (overvalued). Cautious scenario 6,671 KRW, optimistic scenario 12,635 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of The BORN Korea (475560)?
The BORN Korea reported trailing-twelve-month revenue of about 339B KRW (latest available figure, as of Oct 2, 2026).
Does The BORN Korea pay a dividend?
The BORN Korea currently shows a dividend yield of about 3.55% relative to its recent price (as of Oct 2, 2026).
What is the intrinsic value of The BORN Korea (475560)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For The BORN Korea it is 10,108 KRW per share (as of Oct 2, 2026), against a price of 14,100 KRW. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is The BORN Korea stock overvalued or undervalued in 2026?
As of Oct 2, 2026, 475560 trades above its calculated fair value: price 14,100 KRW, fair value 10,108 KRW, a gap of about −28% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 475560?
No. The price is what the market pays today (14,100 KRW); the fair value is what the company's own numbers justify (10,108 KRW). For The BORN Korea the two are 3,992 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is The BORN Korea worth?
The market values The BORN Korea at about 208B KRW (market capitalisation, as of Oct 2, 2026). Per share that is 14,100 KRW; our models calculate a fair value of 10,108 KRW per share.
What do the bullish and bearish scenarios say about 475560?
Our models span a range for The BORN Korea: cautious scenario 6,671 KRW, base 10,108 KRW, optimistic 12,635 KRW per share (as of Oct 2, 2026, price 14,100 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of The BORN Korea (475560)?
Balance-sheet figures for The BORN Korea (as of Oct 2, 2026): return on equity −2.7%, debt of 0.00 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is 475560 from its 52-week high?
The BORN Korea trades at 14,100 KRW, about 46% below its 52-week high of 25,948 KRW and 11% above the low of 12,700 KRW (as of Oct 8, 2026). Distance from the high says nothing about value: that is what the fair value of 10,108 KRW is for.
Which stocks are comparable to The BORN Korea?
From the same area (Consumer Cyclical) we also value McDonald's Corporation, Starbucks Corporation, Chipotle Mexican Grill, Inc, Yum! Brands, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is The BORN Korea stock attractive at the current price?
The data as of Oct 2, 2026: price 14,100 KRW, calculated fair value 10,108 KRW (−28%), Quality Score 41/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 475560 calculated?
We run The BORN Korea through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 10,108 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. The BORN Korea itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of The BORN Korea (475560)?
The closing price on Oct 8, 2026 was 14,100 KRW. Our model-based fair value is 10,108 KRW, about −28% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with The BORN Korea right now?
The price sits above even our optimistic bull case (12,635 KRW). The favourable scenario is already priced in. Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (6,671 KRW to 12,635 KRW) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of The BORN Korea

How large is the market capitalisation of The BORN Korea (475560)?
The market capitalisation of The BORN Korea is 208B KRW (≈ $155M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of The BORN Korea (475560)?
The price-to-sales ratio of The BORN Korea is 0.63 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of The BORN Korea (475560)?
The dividend yield of The BORN Korea is 3.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of The BORN Korea (475560)?
The net margin of The BORN Korea is −4.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of The BORN Korea (475560)?
The return on equity (ROE) of The BORN Korea is −2.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of The BORN Korea (475560)?
On an EBIT basis the return on assets of The BORN Korea is 8.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of The BORN Korea (475560)?
The operating margin of The BORN Korea is −6.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at The BORN Korea (475560)?
Revenue at The BORN Korea is growing +12.2% versus a year earlier (3y avg +8.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at The BORN Korea (475560)?
Earnings per share at The BORN Korea are growing −72.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does The BORN Korea (475560) generate?
The free cash flow of The BORN Korea is −44.1B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch The BORN Korea in the live analysis

One click puts The BORN Korea on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.